non-Hodgkin lymphoma Antibody-drug conjugates targeted to CD79 for the treatment of

作者： Suzie J. Scales , Kristi Elkins , Jean-Philippe Stephan , Andrew G. Polson , Jo-Anne Hongo

DOI:

关键词: Hodgkin lymphoma 、 Humanities 、 History

摘要: doi:10.1182/blood-2007-01-066704Prepublished online March 20, 2007;2007 110: 616-623€€€€Sarajane Ross, Dan Eaton and Allen EbensMary J. Cole, Richard Vandlen, Jean-Philippe Stephan, Judy Young, Wesley Chang, Suzie Scales,Dionysos S. Slaga, Lynne Giere, Changchun Du, Christine Tan, Jo-Anne Hongo, Alvin Gogineni, Andrew G. Polson, Shang-Fan Yu, Kristi Elkins, Bing Zheng, Suzanna Clark, Gladys Ingle,€

暂无可下载资源，当前可以选择系统获取到有开放资源时通知我或者直接发起求助文献求助

参考文章(35)

Power Mj, Zhang L, Glennie Mj, Chan Ht, O'Keefe Tl, Cragg Ms, French Rr, The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. Therapeutic immunology. ,vol. 2, pp. 191- 202 ,(1995)

M Okazaki, Y Luo, T Han, M Yoshida, BK Seon, Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin‧s lymphoma and are effectively internalized after binding to the cell surface antigen Blood. ,vol. 81, pp. 84- 94 ,(1993) , 10.1182/BLOOD.V81.1.84.84

WM Vuist, R Levy, DG Maloney, Lymphoma Regression Induced by Monoclonal Anti-Idiotypic Antibodies Correlates With Their Ability to Induce Ig Signal Transduction and Is Not Prevented by Tumor Expression of High Levels of Bcl-2 Protein Blood. ,vol. 83, pp. 899- 906 ,(1994) , 10.1182/BLOOD.V83.4.899.899

Hiroaki Niiro, Edward A. Clark, Regulation of B-cell fate by antigen-receptor signals Nature Reviews Immunology. ,vol. 2, pp. 945- 956 ,(2002) , 10.1038/NRI955

Krista B. Condon, Richard N. Mitchell, Paul Webster, James R. Drake, Timothy A. Lewis, Involvement of MIIC-Like Late Endosomes in B Cell Receptor-Mediated Antigen Processing in Murine B Cells Journal of Immunology. ,vol. 162, pp. 1150- 1155 ,(1999)

Jennifer Lippincott-Schwartz, Lydia Yuan, Christopher Tipper, Myléne Amherdt, Lelio Orci, Richard D. Klausner, Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic Cell. ,vol. 67, pp. 601- 616 ,(1991) , 10.1016/0092-8674(91)90534-6

Hans K. Erickson, Peter U. Park, Wayne C. Widdison, Yelena V. Kovtun, Lisa M. Garrett, Karen Hoffman, Robert J. Lutz, Victor S. Goldmacher, Walter A. Blättler, Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing Cancer Research. ,vol. 66, pp. 4426- 4433 ,(2006) , 10.1158/0008-5472.CAN-05-4489

Linda Matsuuchi, Michael R Gold, New views of BCR structure and organization Current Opinion in Immunology. ,vol. 13, pp. 270- 277 ,(2001) , 10.1016/S0952-7915(00)00215-6

Tetsuya Nakamura, M. Chandra Sekar, Hiromi Kubagawa, Max D. Cooper, Signal transduction in human B cells initiated via Igβ ligation International Immunology. ,vol. 5, pp. 1309- 1315 ,(1993) , 10.1093/INTIMM/5.10.1309

10.

Martin C Garnett, Targeted drug conjugates: principles and progress Advanced Drug Delivery Reviews. ,vol. 53, pp. 171- 216 ,(2001) , 10.1016/S0169-409X(01)00227-7

non-Hodgkin lymphoma Antibody-drug conjugates targeted to CD79 for the treatment of

来源期刊

我的账户

non-Hodgkin lymphoma Antibody-drug conjugates targeted to CD79 for the treatment of

来源期刊

相似文章 0

我的账户